180 related articles for article (PubMed ID: 1333909)
1. Assessment of chemoembolization therapy for primary liver cancer using a stabilized adriamycin-lipiodol suspension.
Horiguchi Y; Itoh M; Takagawa H; Imai H; Kamei A; Sekoguchi B; Nagamura Y
Cancer Chemother Pharmacol; 1992; 31 Suppl():S60-4. PubMed ID: 1333909
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma.
Ono Y; Yoshimasu T; Ashikaga R; Inoue M; Shindou H; Fuji K; Araki Y; Nishimura Y
Am J Clin Oncol; 2000 Dec; 23(6):564-8. PubMed ID: 11202797
[TBL] [Abstract][Full Text] [Related]
3. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma.
Aoyama K; Tsukishiro T; Okada K; Tsuchida T; Aiba N; Nambu S; Miyabayashi C; Yasuyama T; Higuchi K; Watanabe A
Cancer Chemother Pharmacol; 1992; 31 Suppl():S55-9. PubMed ID: 1281046
[TBL] [Abstract][Full Text] [Related]
5. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion.
Kamada K; Nakanishi T; Kitamoto M; Aikata H; Kawakami Y; Ito K; Asahara T; Kajiyama G
J Vasc Interv Radiol; 2001 Jul; 12(7):847-54. PubMed ID: 11435541
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE).
Yodono H; Takekawa SD; Tarusawa K; Ikami I; Kanehira J; Saito Y; Takahashi S; Sasaki T; Nishi N; Kimura T
Cancer Chemother Pharmacol; 1994; 33 Suppl():S79-83. PubMed ID: 8137489
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.
Nakao N; Uchida H; Kamino K; Nishimura Y; Ohishi H; Takayasu Y; Nakamura H; Kuroda C; Fujita M; Yoshioka H
Cancer Chemother Pharmacol; 1992; 31 Suppl():S72-6. PubMed ID: 1333913
[TBL] [Abstract][Full Text] [Related]
8. Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings.
Matsuo N; Uchida H; Sakaguchi H; Nishimine K; Nishimura Y; Hirohashi S; Ohishi H
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-61-S6-70. PubMed ID: 9151919
[TBL] [Abstract][Full Text] [Related]
9. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
Hirashima N; Sakakibara K; Itazu I; Hirai T; Nemoto A; Matsuura H; Kumada K; Nojiri O; Kano H
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-91-S6-96. PubMed ID: 9151922
[TBL] [Abstract][Full Text] [Related]
10. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
11. Treatment of choice for unresectable small liver cancer: percutaneous ethanol injection therapy or transarterial chemoembolization therapy.
Horiguchi Y; Sekoguchi B; Imai H; Suzuki T; Kubo H; Itoh H; Itoh M
Cancer Chemother Pharmacol; 1994; 33 Suppl():S111-4. PubMed ID: 8137468
[TBL] [Abstract][Full Text] [Related]
12. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
[TBL] [Abstract][Full Text] [Related]
13. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
Kawai S; Okamura J; Ogawa M; Ohashi Y; Tani M; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C
Cancer Chemother Pharmacol; 1992; 31 Suppl():S1-6. PubMed ID: 1281041
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of preoperative transcatheter arterial embolization in the treatment of resectable primary liver cancer.
Nagasue N; Kohno H; Uchida M
Semin Surg Oncol; 1993; 9(4):327-31. PubMed ID: 8210914
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma.
Uchida H; Ohishi H; Matsuo N; Nishimine K; Ohue S; Nishimura Y; Maeda M; Yoshioka T
Cardiovasc Intervent Radiol; 1990; 13(3):140-5. PubMed ID: 2171772
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinoma.
Ohishi H; Yoshimura H; Uchida H; Sakaguchi H; Yoshioka T; Ohue S; Matsui T; Takaya A; Tsujii T
Cancer Chemother Pharmacol; 1989; 23 Suppl():S33-6. PubMed ID: 2538263
[TBL] [Abstract][Full Text] [Related]
19. [Studies on combination therapy with TAE and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma].
Tateishi H; Hasuike Y; Kinuta M; Furukawa J; Takata N; Maruyama H; Oi H; Yayoi E; Okamura J
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1492-4. PubMed ID: 8396903
[TBL] [Abstract][Full Text] [Related]
20. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results.
Nishimine K; Uchida H; Matsuo N; Sakaguchi H; Hirohashi S; Nishimura Y; Guo Q; Ohishi H; Nagano N; Yoshioka T
Cancer Chemother Pharmacol; 1994; 33 Suppl():S60-8. PubMed ID: 7511069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
